Found: 10
Select item for more details and to access through your institution.
CARISEL Çalışmasının Bir Etkililik ve Güvenlilik Alt Grup Analizi.
- Published in:
- Mediterranean Journal of Infection, Microbes & Antimicrobials, 2024, v. 13, p. 105
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase 3, Noninferiority SALSA Randomized Trial
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 4, p. 720, doi. 10.1093/cid/ciac130
- By:
- Publication type:
- Article
Disseminated Mycobacterium abscessus Infection Secondary to an Infected Vascular Stent: Case Report and Review of the Literature.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 9, p. N.PAG, doi. 10.1093/ofid/ofy207
- By:
- Publication type:
- Article
Implementation of long‐acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations.
- Published in:
- Journal of the International AIDS Society, 2024, v. 27, n. 7, p. 1, doi. 10.1002/jia2.26243
- By:
- Publication type:
- Article
Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies.
- Published in:
- AIDS Research & Therapy, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12981-024-00604-9
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to Dolutegravir/ Lamivudine (DTG/3TC) in Treatment-Experienced, Virologically Suppressed PLHIV Aged ≥50 Years: Pooled Results From the TANGO and SALSA Studies.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 273
- By:
- Publication type:
- Article
Efficacy and Safety of Switching to Dolutegravir/ Lamivudine by Baseline Regimen in Virologically Suppressed Adults: 48-Week Pooled Analysis.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. 271
- By:
- Publication type:
- Article
Week 48 metabolic health after switch to DTG/3TC vs CAR by baseline regimen (SALSA).
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. S300
- By:
- Publication type:
- Article
Switching to DTG/3TC Is non-inferior to continuing current antiretroviral regimen at week 48: SALSA subgroup analyses.
- Published in:
- Infection & Chemotherapy, 2022, v. 54, p. S298
- By:
- Publication type:
- Article
Effect of Food on the Pediatric Dispersible Tablet Formulations of TRIUMEQ and DOVATO in Healthy Adult Participants.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 5, p. 1470, doi. 10.3390/pharmaceutics15051470
- By:
- Publication type:
- Article